Word: pays
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...servers--Linux is already a threat to Microsoft, says Eric Raymond, a Linux evangelist. Linux runs on nearly a third of all servers, and according to Raymond, it will soon make similar inroads in the consumer market. His reasoning: as computer prices spiral downward, the price PC manufacturers pay to license Windows grows proportionately, cutting into their meager margins. PC makers will "start defecting en masse to Linux," Raymond predicts, "because they can no longer make money partnered with Microsoft...
Cost shouldn't be a consideration. Most clinical trials are free to patients; some even pay their subjects. Insurance companies in the past have been reluctant to cover the nonexperimental part of the treatment, but they are starting to come around...
...that life in Beverly Hills is bound to be more exciting. She is one of those irritating people who cover wrongheadedness with eccentric excess. This is supposed to be charming, but it is merely tiresome. Portman pouts prettily at Adele's all too predictable capers--naturally she forgets to pay the utility bills, misreads her daughter's dreams and that handsome orthodontist's intentions. But you can feel these beats coming--thump, thump--a mile off, and Wang's inert direction does nothing to enliven their inevitable arrival...
...course, Schering-Plough would pay almost any amount of money to protect its exclusive right to sell Claritin, a drug that brings it more than $5 million in revenue a day. Claritin sales totaled $1.9 billion last year, and will balloon to $4 billion by 2002, according to a market analyst. To keep the money coming in, the company doubled its lobbying outlay starting in 1996 to more than $4 million in 1998. Among its other paid advocates: former Senator Dennis DeConcini; former Watergate assistant special prosecutor Richard Ben-Veniste; and Thomas Parry, former chief of staff for Senator Orrin...
...only fair. Claritin was stuck in the Food and Drug Administration approval pipeline longer than many drugs, it claims, with the clock ticking on its 17-year patent. Schering-Plough also says Claritin profits help fund research for new drugs. But, its opponents counter, what about Claritin patients--who pay as much as $2.66 a dose instead of the 50[cents] or less they would pay, analysts figure, if a generic version of the drug were available? If the patent expires on time, according to a University of Minnesota study funded in part by the generic-drug industry, consumers could...